← 返回

仿生金纳米调节剂通过气态微环境重塑策略用于深部肿瘤 NIR-II 光热免疫治疗

英文原题:Biomimetic gold nano-modulator for deep-tumor NIR-II photothermal immunotherapy via gaseous microenvironment remodeling strategy.

查看英文原题

Biomimetic gold nano-modulator for deep-tumor NIR-II photothermal immunotherapy via gaseous microenvironment remodeling strategy.

PubMed 2025/03/18(内容时间) J Nanobiotechnology Q1 · IF 15(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

工程化仿生纳米调节剂 GNR-SNO@MMT 通过 NO 参与的纳米药物和外部 NIR-II 激光辅助实现免疫重构,为深部实体瘤提供了一种有效且新颖的光免疫治疗候选方案。

研究思路结论见上方概要

实体瘤的有效免疫治疗受到复杂且不利的肿瘤免疫抑制微环境(TIME)的极大挑战,该微环境通常涉及缺氧和免疫抑制。

本文开发了一种多功能仿生金纳米调节剂(记为 GNR-SNO@MMT),通过肿瘤靶向与深层穿透、血管正常化及免疫重编程,实现高效的 second near-infrared (NIR-II) 光热免疫治疗。将 NIR-II 光热剂金纳米棒(GNR)接枝热敏 S-nitrosothiol (SNO) 供体,并用肿瘤穿透肽 tLyp-1 修饰的巨噬细胞膜(MM)进行伪装,得到 GNR-SNO@MMT。

工程化膜涂层增强了肿瘤炎症趋向性和深度穿透能力,这有助于GNR-SNO@MMT联合NIR-II激光照射消融肿瘤。此外,热疗刺激下原位释放的一氧化氮(NO)作为气体免疫调节剂,通过多种功能(如降低PD-L1、重极化肿瘤相关巨噬细胞和重新激活细胞毒性T细胞)有效增强血液灌注并重编程TIME。最终,GNR-SNO@MMT联合NIR-II激光对4T1小鼠乳腺肿瘤模型介导的抑制率为94.7%,且浸润肿瘤的CD8+ T细胞是未处理对照组的2.4倍。

展开英文摘要原文

Herein, a multifunctional biomimetic gold nano-modulator (denoted as GNR-SNO@MMT) was developed to realize the efficient second near-infrared (NIR-II) photothermal immunotherapy via tumor targeting and deep penetration, vascular normalization and immune reprogramming. NIR-II photothermal agent gold nanorods (GNR) were grafted with thermosensitive S-nitrosothiol (SNO) donors and camouflaged with the tumor-penetrating peptide tLyp-1-modified macrophage membrane (MM) to yield GNR-SNO@MMT.

The engineered membrane coating increased the capacity for tumor inflammatory tropism and deep penetration, which aided GNR-SNO@MMT in ablating tumors together with NIR-II laser irradiation. Moreover, hyperthermia-stimulated nitric oxide (NO) release in situ acted as a gas immunomodulator to effectively enhance blood perfusion and reprogram the TIME via multiple functions (e.g., decreasing PD-L1, repolarizing tumor-associated macrophages, and revitalizing cytotoxic T cells). Ultimately, the inhibition rate against 4T1 mouse mammary tumor model mediated by GNR-SNO@MMT plus NIR-II laser was 94.7% together with 2.4-fold CD8 + T cells infiltrated into tumors than that of the untreated counterpart.

The engineered biomimetic nano-modulator of GNR-SNO@MMT provides an effective and novel photoimmunotherapy candidate against deep-sited solid tumors through immune reconfiguration via NO-involved nanomedicine and external NIR-II laser assistance.

论文信息

作者
Huang H、Xie Z、Li N、Zeng L、Zeng Q、Yang Z、Shen J、Yang H
第一作者单位
Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610041, P. R. China.China
通讯作者单位
Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610041, P. R. China. wuchunhui@uestc.edu.cn.China
期刊
Journal of nanobiotechnology2025 Mar 18
原文标识
PubMed 40102878 · DOI 10.1186/s12951-025-03304-2